Literature DB >> 973962

The influence of various factors in the in vitro distribution of haloperidol in human blood.

I E Hughes, L B Jellett, K F Ilett.   

Abstract

Haloperidol is 89.6+/-0.3% bound (mean+/-s.e. mean) in human plasma under in vitro conditions and the free drug distributes rapidly between the plasma and the cellular elements of blood. The cell/plasma partition ratio was 1.12+/-0.06 (mean+/-s.e. mean). Alteration of plasma binding by dilution with buffer showed that uptake of haloperidol by the cellular elements of blood was proportional to free drug concentration. Bishydroxycoumarin (95 ot 286 mug/ml) reduced plasma binding of haloperidol and the displaced haloperidol was taken up by the cellular blood elements. The experiments indicate that the cellular compartment of blood as well as the plasma compartment may act as a sink for haloperidol and drug displacement interactions should therefore be interpreted with a knowledge of both of these compartments.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 973962      PMCID: PMC1428865          DOI: 10.1111/j.1365-2125.1976.tb00605.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

1.  Passage of organic bases into human red cells.

Authors:  L S SCHANKER; P A NAFPLIOTIS; J M JOHNSON
Journal:  J Pharmacol Exp Ther       Date:  1961-09       Impact factor: 4.030

2.  The distribution of quinidine in human blood.

Authors:  I E Hughes; K F Ilett; L B Jellett
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

3.  Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.

Authors:  P H Hinderling; J Bres; E R Garrett
Journal:  J Pharm Sci       Date:  1974-11       Impact factor: 3.534

4.  Erythrocyte uptake and plasma binding of diphenylhydantoin.

Authors:  D Kurata; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1974-08       Impact factor: 6.875

  4 in total
  5 in total

1.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

2.  Plasma level of chlormethiazole and two metabolites after oral administration to young and aged human subjects.

Authors:  R L Nation; J Vine; E J Triggs; B Learoyd
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

3.  Proceeding of the British Pharmacological Society, Clinical Pharmacology Section, 16-18th December, 1980, University of London. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

4.  Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol.

Authors:  D W Eyles; H A Whiteford; T J Stedman; S M Pond
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Distribution of sodium valproate in normal whole blood and in blood from patients with renal or hepatic disease.

Authors:  R J Shirkey; L B Jellett; D C Kappatos; T J Maling; A Macdonald
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.